Cutler Group LP Abb Vie Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Cutler Group LP holds 1,480 shares of ABBV stock, worth $238,635. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,480

Previous 1,667 11.22%

Holding current value

$238,635

Previous $258,000 4.26%

% of portfolio

0.09%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$159.82 - $182.1 $29,886 - $34,052	-187 Reduced 11.22%	1,480 $269,000
Q4 2023 Jan 18, 2024	SELL	$137.6 - $154.97 $99,622 - $112,198	-724 Reduced 30.28%	1,667 $258,000
Q3 2023 Nov 07, 2023	SELL	$133.59 - $154.65 $232,446 - $269,091	-1,740 Reduced 42.12%	2,391 $356,000
Q2 2023 Jul 18, 2023	SELL	$132.51 - $164.9 $160,602 - $199,858	-1,212 Reduced 22.68%	4,131 $556,000
Q1 2023 May 01, 2023	SELL	$144.61 - $166.54 $1.31 Million - $1.51 Million	-9,041 Reduced 62.85%	5,343 $851,000

Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $910,633 - $1.09 Million	6,584 Added 84.41%	14,384 $2.32 Million
Q3 2022 Oct 25, 2022	SELL	$134.21 - $153.93 $416,453 - $477,644	-3,103 Reduced 28.46%	7,800 $1.05 Million
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $299,048 - $380,188	2,173 Added 24.89%	10,903 $1.67 Million
Q1 2022 Apr 14, 2022	SELL	$131.98 - $163.75 $2.71 Million - $3.37 Million	-20,557 Reduced 70.19%	8,730 $1.42 Million
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $1.26 Million - $1.59 Million	11,706 Added 66.58%	29,287 $3.97 Million
Q3 2021 Oct 26, 2021	SELL	$106.4 - $120.78 $699,686 - $794,249	-6,576 Reduced 27.22%	17,581 $1.9 Million
Q2 2021 Jul 19, 2021	BUY	$105.21 - $117.21 $849,886 - $946,822	8,078 Added 50.24%	24,157 $2.72 Million
Q1 2021 Apr 26, 2021	SELL	$102.3 - $112.62 $1.85 Million - $2.04 Million	-18,114 Reduced 52.98%	16,079 $1.74 Million
Q4 2020 Jan 21, 2021	BUY	$80.49 - $108.67 $2.41 Million - $3.26 Million	29,979 Added 711.41%	34,193 $3.66 Million
Q3 2020 Oct 27, 2020	SELL	$85.91 - $100.83 $492,178 - $577,655	-5,729 Reduced 57.62%	4,214 $369,000
Q2 2020 Jul 22, 2020	SELL	$73.37 - $98.18 $259,509 - $347,262	-3,537 Reduced 26.24%	9,943 $976,000
Q1 2020 May 07, 2020	BUY	$64.5 - $97.79 $694,020 - $1.05 Million	10,760 Added 395.59%	13,480 $1.03 Million
Q4 2019 Feb 06, 2020	SELL	$72.13 - $90.25 $72,130 - $90,250	-1,000 Reduced 26.88%	2,720 $240,000
Q3 2019 Oct 28, 2019	BUY	$62.98 - $75.72 $130,242 - $156,588	2,068 Added 125.18%	3,720 $281,000
Q2 2019 Aug 09, 2019	BUY	$65.7 - $83.98 $16,950 - $21,666	258 Added 18.51%	1,652 $120,000
Q1 2019 May 10, 2019	SELL	$77.14 - $90.79 $509,586 - $599,758	-6,606 Reduced 82.58%	1,394 $112,000
Q4 2018 Feb 05, 2019	BUY	$77.85 - $96.01 $467,099 - $576,060	6,000 Added 300.0%	8,000 $737,000
Q3 2018 Nov 07, 2018	BUY	$88.91 - $98.84 $44,455 - $49,420	500 Added 33.33%	2,000 $189,000
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $161,873 - $191,532	-1,803 Reduced 54.59%	1,500 $138,000
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $630,544 - $844,358	-6,853 Reduced 67.48%	3,303 $312,000
Q4 2017 Jan 17, 2018	BUY	$89.56 - $98.21 $88,395 - $96,933	987 Added 10.76%	10,156 $982,000
Q3 2017 Oct 17, 2017	BUY	$69.85 - $89.22 $640,454 - $818,058	9,169	9,169 $814,000

Others Institutions Holding ABBV

# of Institutions

3,643

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $285B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account